These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11566345)

  • 1. Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas.
    Hoff C; Mollenhauer J; Waldau B; Hamann U; Poustka A
    Cancer Genet Cytogenet; 2001 Sep; 129(2):145-9. PubMed ID: 11566345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
    Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
    Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
    Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
    Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3.
    Stack M; Jones D; White G; Liscia DS; Venesio T; Casey G; Crichton D; Varley J; Mitchell E; Heighway J
    Hum Mol Genet; 1995 Nov; 4(11):2047-55. PubMed ID: 8589680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.
    Rhiem K; Klein A; Münch M; Kreutzfeld R; Ramser J; Wardelmann E; Schackert G; Von Deimling A; Wiestler OD; Schmutzler RK
    Int J Cancer; 2003 Aug; 106(1):74-7. PubMed ID: 12794759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
    Devilee P; Cornelisse CJ; Kuipers-Dijkshoorn N; Jonker C; Pearson PL
    Cytogenet Cell Genet; 1990; 53(1):52-4. PubMed ID: 1969789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers.
    Isomura M; Tanigami A; Saito H; Harada Y; Katagiri T; Inazawa J; Ledbetter DH; Nakamura Y
    Genes Chromosomes Cancer; 1994 Mar; 9(3):173-9. PubMed ID: 7515659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.
    Helland A; Kraggerud SM; Kristensen GB; Holm R; Abeler VM; Huebner K; Borresen-Dale AL; Lothe RA
    Int J Cancer; 2000 Oct; 88(2):217-22. PubMed ID: 11004671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
    Zhao X; Wan D; Jiang H
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.
    Ellsworth RE; Ellsworth DL; Neatrour DM; Deyarmin B; Lubert SM; Sarachine MJ; Brown P; Hooke JA; Shriver CD
    Mol Cancer Res; 2005 Feb; 3(2):71-7. PubMed ID: 15755873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
    Tsuchiya E; Tanigami A; Ishikawa Y; Nishida K; Hayashi M; Tokuchi Y; Hashimoto T; Okumura S; Tsuchiya S; Nakagawa K
    Jpn J Cancer Res; 2000 Jun; 91(6):589-96. PubMed ID: 10874210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency allelic loss on chromosome 17p13.3-p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China.
    Huang J; Hu N; Goldstein AM; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang QH; Dawsey SM; Han XY; Ding T; Li G; Giffen C; Taylor PR
    Carcinogenesis; 2000 Nov; 21(11):2019-26. PubMed ID: 11062163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.